The disease and conditions market is considered a crucial segment within the healthcare industry. The market is expected to pace at a strong rate as the incidence of chronic ailments around the world increases. Besides this, the rising geriatric populations and the prevalence of lifestyle diseases are considered primary factors contributing to the growth of the disease and conditions market.
The accelerating urbanization due to the emerging middle class has bolstered the prevalence of sedentary lifestyle around the world. This in turn is pushing the rate of obesity and the incidence of diabetes upward. The World Health Organization (WHO) forecasts the prevalence of chronic illnesses to increase by 57% by the end of 2020. The emerging countries will be hit the hardest, as they witness exponential population growth. The rising incidence of chronic ailments exercises increased pressure on the healthcare industry across these countries, which has shaped into a major concern.
Besides this, the globally rising pandemics is a critical concern demanding immediate attention of governments around the world. Pandemics that were popular in the past decade have demonstrated the potential speed at which they can spread across the globe. SARS, Ebola, H1N1, and MERS, to name a few, require agile healthcare responses and coordinated efforts. These pandemics are capable of exerting periodic yet significant disruptive pressure on the healthcare infrastructure. It is therefore essential for healthcare organizations worldwide to work in unison to contain the outbreak quickly whenever they occur.
New delivery models are innovated to address the rising chronic care and conditions demands. The technology has a key role to play in the healthcare industry. Advancements are also required to ensure accurate detection and precise diagnosis of ailments to minimize the cost incurred on the treatment of disease and conditions. Knowledge on molecular diagnostics and genome sequencing has thus provided better understanding of the nature of diseases and has helped in the development of personalized treatment markets.
Furthermore, the emergence of new players in the disease and conditions market has been reshaping the healthcare system. The industry is now attaching greater emphasis on patient-centric care and preventive health solutions. The development has also created opportunities for the entry of enterprises operating in sectors such as technology, wellness, telecommunications, and fitness. The entry of new players has thus brought innovative solutions for chronic disease prevention and has helped in mitigating the associated management challenges.
Much to the benefit of the disease and conditions market, international collaborations due to the rising pressure on healthcare and social systems are providing governments with opportunities to offset the growing financial burden. In turn, these companies have gained new markets to capitalize on. The new delivery models to curb the prevalence of chronic disease and conditions are providing global access to advanced technologies.
The aforementioned developments will aid the expansion of the disease and conditions market, thereby augmenting overall growth witnessed by the healthcare industry. Besides this, the market is also expected to gain impetus from the launch of novel technologies and the proliferation of patient-centric approaches such as home healthcare.